iRhythm Holdings (IRTC) stock: insider trades, news & valuation
Net selling
Close · Oct 9, 2026
$106.70
+4.0% on the day
-39.6% over 12 months
52-week range $101.79 – $189.25
Share price and insider trades
IRTC closeInsider buyInsider sale
Bought, 12 months$57K
Sold, 12 months$29.6M
Insiders buying1
Insiders selling12
iRhythm Holdings insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $57K and 12 sold $29.6M of IRTC stock on the open market.
Get emailed when insiders cluster-buy stocks like IRTC
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
IRTC insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $7.7M | 11 |
| Q2 2026 | $57K | 1 | $1.0M | 8 |
| Q1 2026 | — | 0 | $15.2M | 37 |
| Q4 2025 | — | 0 | $5.7M | 10 |
Valuation, profit and volume
P/E (trailing)n/aSector median —
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day0.9×Last 5 sessions
Insiders' paper profit+$510KOn all tracked purchases +896.3%
Summary
Over the past 12 months, 1 iRhythm Holdings, Inc. insider reported open-market purchases totaling $57K, while 12 insiders reported sales totaling $29.6M. 20 of 66 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 3SEC | Daniel G. WilsonCFO | Sell | 77334,887 held (−2%) | $121.83 | $94K | -12.4% | — |
| Aug 11SEC | Quentin S. BlackfordCEO, President | Sell | 26,859226,008 held (−11%) | $124.65 | $3.3M | -14.4% | — |
| Aug 11SEC | Patrick Michael MurphyGeneral Counsel | Sell | 7,09369,699 held (−9%) | $124.65 | $884K | -14.4% | — |
| Aug 11SEC | Minang TurakhiaChief Med/Sci Ofcr Evp Advtech | Sell | 7,09360,116 held (−11%) | $124.65 | $884K | -14.4% | — |
| Aug 11SEC | Chad PattersonChief Comm & Product Officer | Sell | 7,09362,125 held (−10%) | $124.65 | $884K | -14.4% | — |
| Aug 11SEC | Sumi ShrishrimalEvp, Chief Risk Officer | Sell | 5,37244,621 held (−11%) | $124.65 | $670K | -14.4% | — |
| Aug 4SEC | Chad PattersonChief Comm & Product Officer | Sell | 2,71255,629 held (−5%) | $122.12 | $331K | -12.6% | — |
| Aug 4SEC | Julianne RoddaEvp, Chief People Officer | Sell | 2,11218,201 held (−10%) | $122.12 | $258K | -12.6% | — |
| Aug 4SEC | Mervin SmithEvp Strategic Business Ops | Sell | 61722,410 held (−3%) | $122.12 | $75K | -12.6% | — |
| Jul 6SEC | Minang TurakhiaChief Med/Sci Ofcr Evp Advtech | Sell | 1,42353,620 held (−3%) | $124.71 | $177K | -14.4% | — |
| Jul 6SEC | Sean Clinton FreemanEvp, Strategy & Corp Devt | Sell | 91813,641 held (−6%) | $124.71 | $114K | -14.4% | — |
| Jun 3SEC | Sumi ShrishrimalEvp, Chief Risk Officer | Sell | 1,71640,287 held (−4%) | $108.19 | $186K | -1.4% | — |
| Jun 3SEC | Marc Wade RosenbaumChief Accounting Officer | Sell | 72916,155 held (−4%) | $108.19 | $79K | -1.4% | — |
| May 12SEC | Abhijit Y TalwalkarDirector | Sell Plan | 2,29321,736 held (−10%) | $118.02 | $271K | -9.6% | — |
| May 12SEC | Abhijit Y TalwalkarDirector | Sell Plan | 1,14720,589 held (−5%) | $119.16 | $137K | -10.5% | — |
| May 12SEC | Abhijit Y TalwalkarDirector | Sell Plan | 94024,671 held (−4%) | $116.05 | $109K | -8.1% | — |
| May 12SEC | Abhijit Y TalwalkarDirector | Sell Plan | 64224,029 held (−3%) | $116.98 | $75K | -8.8% | — |
| May 12SEC | Abhijit Y TalwalkarDirector | Buy | 5,31225,611 held (+26%) | $10.71 | $57K | +896.3% | — |
| May 12SEC | Abhijit Y TalwalkarDirector | Sell Plan | 29020,299 held (−1%) | $120.53 | $35K | -11.5% | — |
| May 5SEC | Brian Lee LawrenceCTO | Sell | 1,01420,154 held (−5%) | $120.80 | $122K | -11.7% | — |
| Mar 17SEC | Mervin SmithEvp Strategic Business Ops | Sell Plan | 2,58523,027 held (−10%) | $114.30 | $295K | -6.6% | — |
| Mar 3SEC | Quentin S. BlackfordCEO, President | Sell | 5,423204,155 held (−3%) | $128.44 | $697K | -16.9% | — |
| Mar 3SEC | Quentin S. BlackfordCEO, President | Sell | 4,347213,621 held (−2%) | $128.44 | $558K | -16.9% | — |
| Mar 3SEC | Quentin S. BlackfordCEO, President | Sell | 4,043209,578 held (−2%) | $128.44 | $519K | -16.9% | — |
| Mar 3SEC | Chad PattersonChief Comm & Product Officer | Sell | 3,03058,164 held (−5%) | $128.44 | $389K | -16.9% | — |
| Mar 3SEC | Patrick Michael MurphyGeneral Counsel | Sell | 2,02865,532 held (−3%) | $128.44 | $260K | -16.9% | — |
| Mar 3SEC | Minang TurakhiaChief Med/Sci Ofcr Evp Advtech | Sell | 1,48757,446 held (−3%) | $128.45 | $191K | -16.9% | — |
| Mar 3SEC | Chad PattersonChief Comm & Product Officer | Sell | 1,41461,194 held (−2%) | $128.44 | $182K | -16.9% | — |
| Mar 3SEC | Minang TurakhiaChief Med/Sci Ofcr Evp Advtech | Sell | 1,31056,136 held (−2%) | $128.45 | $168K | -16.9% | — |
| Mar 3SEC | Daniel G. WilsonCFO | Sell | 1,26135,660 held (−3%) | $128.45 | $162K | -16.9% | — |
| Mar 3SEC | Minang TurakhiaChief Med/Sci Ofcr Evp Advtech | Sell | 1,23054,906 held (−2%) | $128.45 | $158K | -16.9% | — |
| Mar 3SEC | Patrick Michael MurphyGeneral Counsel | Sell | 1,19064,342 held (−2%) | $128.44 | $153K | -16.9% | — |
| Mar 3SEC | Patrick Michael MurphyGeneral Counsel | Sell | 1,13963,203 held (−2%) | $128.45 | $146K | -16.9% | — |
| Mar 3SEC | Sumi ShrishrimalEvp, Chief Risk Officer | Sell | 97841,870 held (−2%) | $128.44 | $126K | -16.9% | — |
| Mar 3SEC | Sumi ShrishrimalEvp, Chief Risk Officer | Sell | 94643,754 held (−2%) | $128.44 | $122K | -16.9% | — |
| Mar 3SEC | Sumi ShrishrimalEvp, Chief Risk Officer | Sell | 90642,848 held (−2%) | $128.44 | $116K | -16.9% | — |
| Mar 3SEC | Daniel G. WilsonCFO | Sell | 81537,485 held (−2%) | $128.44 | $105K | -16.9% | — |
| Mar 3SEC | Daniel G. WilsonCFO | Sell | 75538,300 held (−2%) | $128.44 | $97K | -16.9% | — |
| Mar 3SEC | Mervin SmithEvp Strategic Business Ops | Sell | 75226,212 held (−3%) | $128.44 | $97K | -16.9% | — |
| Mar 3SEC | Mervin SmithEvp Strategic Business Ops | Sell | 60025,612 held (−2%) | $128.44 | $77K | -16.9% | — |
| Mar 3SEC | Daniel G. WilsonCFO | Sell | 56436,921 held (−2%) | $128.45 | $72K | -16.9% | — |
| Mar 3SEC | Marc Wade RosenbaumChief Accounting Officer | Sell | 41716,706 held (−2%) | $128.45 | $54K | -16.9% | — |
| Mar 3SEC | Marc Wade RosenbaumChief Accounting Officer | Sell | 39917,123 held (−2%) | $128.45 | $51K | -16.9% | — |
| Feb 26SEC | Quentin S. BlackfordCEO, President | Sell | 25,540186,126 held (−12%) | $135.42 | $3.5M | -21.2% | — |
| Feb 26SEC | Chad PattersonChief Comm & Product Officer | Sell | 8,96751,738 held (−15%) | $135.42 | $1.2M | -21.2% | — |
| Feb 26SEC | Patrick Michael MurphyGeneral Counsel | Sell | 7,80560,536 held (−11%) | $135.42 | $1.1M | -21.2% | — |
| Feb 26SEC | Minang TurakhiaChief Med/Sci Ofcr Evp Advtech | Sell | 7,80448,899 held (−14%) | $135.42 | $1.1M | -21.2% | — |
| Feb 26SEC | Sumi ShrishrimalEvp, Chief Risk Officer | Sell | 6,21739,182 held (−14%) | $135.42 | $842K | -21.2% | — |
| Feb 26SEC | Daniel G. WilsonCFO | Sell | 5,18830,694 held (−14%) | $135.42 | $703K | -21.2% | — |
| Feb 26SEC | Marc Wade RosenbaumChief Accounting Officer | Sell | 4,79715,014 held (−24%) | $135.42 | $650K | -21.2% | — |
| Feb 26SEC | Mervin SmithEvp Strategic Business Ops | Sell | 4,04120,275 held (−17%) | $135.42 | $547K | -21.2% | — |
| Feb 25SEC | Mervin SmithEvp Strategic Business Ops | Sell Plan | 73215,106 held (−5%) | $140.91 | $103K | -24.3% | — |
| Feb 25SEC | Marc Wade RosenbaumChief Accounting Officer | Sell Plan | 28010,601 held (−3%) | $140.91 | $39K | -24.3% | — |
| Feb 24SEC | Abhijit Y TalwalkarDirector | Sell Plan | 1,72522,508 held (−7%) | $145.32 | $251K | -26.6% | — |
| Feb 24SEC | Abhijit Y TalwalkarDirector | Sell Plan | 1,63720,299 held (−7%) | $147.62 | $242K | -27.7% | — |
| Feb 24SEC | Abhijit Y TalwalkarDirector | Sell Plan | 1,37824,233 held (−5%) | $143.40 | $198K | -25.6% | — |
| Feb 24SEC | Abhijit Y TalwalkarDirector | Sell Plan | 57221,936 held (−3%) | $146.95 | $84K | -27.4% | — |
| Dec 3SEC | Patrick Michael MurphyGeneral Counsel | Sell | 2,47853,281 held (−4%) | $184.83 | $458K | -42.3% | — |
| Dec 3SEC | Chad PattersonChief Comm & Product Officer | Sell Plan | 28043,387 held (−1%) | $184.83 | $52K | -42.3% | — |
| Nov 12SEC | Abhijit Y TalwalkarDirector | Sell Plan | 1,58522,325 held (−7%) | $174.38 | $276K | -38.8% | — |
| Nov 12SEC | Abhijit Y TalwalkarDirector | Sell Plan | 1,47924,132 held (−6%) | $172.32 | $255K | -38.1% | — |
| Nov 12SEC | Abhijit Y TalwalkarDirector | Sell Plan | 1,30021,025 held (−6%) | $174.94 | $227K | -39.0% | — |
| Nov 12SEC | Abhijit Y TalwalkarDirector | Sell Plan | 63720,388 held (−3%) | $175.96 | $112K | -39.4% | — |
| Nov 12SEC | Abhijit Y TalwalkarDirector | Sell Plan | 22223,910 held (−1%) | $172.83 | $38K | -38.3% | — |
| Nov 12SEC | Abhijit Y TalwalkarDirector | Sell Plan | 8920,299 held (−0%) | $177.85 | $16K | -40.0% | — |
| Nov 4SEC | Quentin S. BlackfordCEO, President | Sell | 14,059164,979 held (−8%) | $182.94 | $2.6M | -41.7% | — |
| Nov 3SEC | Daniel G. WilsonCFO | Sell Plan | 8,00026,470 held (−23%) | $207.44 | $1.7M | -48.6% | — |
Insiders at iRhythm Holdings, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Quentin S. BlackfordCEO, President | — | $11.2M | Aug 11, 2026 | — |
| Chad PattersonChief Comm & Product Officer | — | $3.1M | Aug 11, 2026 | — |
| Patrick Michael MurphyGeneral Counsel | — | $3.0M | Aug 11, 2026 | — |
| Daniel G. WilsonCFO | — | $2.9M | Sep 3, 2026 | — |
| Minang TurakhiaChief Med/Sci Ofcr Evp Advtech | — | $2.6M | Aug 11, 2026 | — |
| Abhijit Y TalwalkarDirector | $57K | $2.3M | May 12, 2026 | — |
| Sumi ShrishrimalEvp, Chief Risk Officer | — | $2.1M | Aug 11, 2026 | — |
| Mervin SmithEvp Strategic Business Ops | — | $1.2M | Aug 4, 2026 | — |
| Marc Wade RosenbaumChief Accounting Officer | — | $873K | Jun 3, 2026 | — |
| Julianne RoddaEvp, Chief People Officer | — | $258K | Aug 4, 2026 | — |
| Brian Lee LawrenceCTO | — | $122K | May 5, 2026 | — |
| Sean Clinton FreemanEvp, Strategy & Corp Devt | — | $114K | Jul 6, 2026 | — |
IRTC stock: common questions
Are iRhythm Holdings, Inc. insiders buying IRTC stock?
In the past 12 months, 1 insiders reported open-market purchases of IRTC worth $57K. The latest was Director Abhijit Y Talwalkar bought $57K of IRTC at $10.71 — first open-market purchase in our records; raises the stake by 26%.
Are iRhythm Holdings, Inc. insiders selling IRTC stock?
12 insiders reported sales worth $29.6M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is IRTC's 52-week range?
Over the past year IRTC has traded between $101.79 and $189.25. It last closed at $106.70 on Oct 9, 2026.